Author:
Fang Xiaomei,Tao Guofang,Zhou Hua,Zhou Yuxia
Reference47 articles.
1. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2021
2. Vaccination reduces need for emergency care in breakthrough COVID-19 infections: a multicenter cohort study;Bahl;The Lancet Regional Health-Americas,2021
3. Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalization - five veterans affairs medical centers, united states, february 1-august 6, 2021;Bajema;MMWR Morb. Mortal. Wkly Rep.,2021
4. SARS-CoV-2 vaccines, vaccine development technologies, and significant efforts in vaccine development during the pandemic: the lessons learned might help to fight against the next pandemic;Chakraborty;Vaccines (basel),2023
5. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial;Chen;Lancet Microbe,2022